Traditional treatment options for chronic health conditions are often aimed at people who are already sick. But what if we could flip the script? Novo Nordisk is driving a paradigm shift in how chronic diseases will be addressed in the future, and researchers at Novo Nordisk’s research center in Seattle are leading an aspirational charge to pioneer scientific breakthroughs aimed at preventing and ultimately curing chronic disease.
Join us for a conversation with Novo Nordisk researchers Dr. Wesley and Dr. Grove, and a person living with type 1 diabetes, to learn about challenges with discovering novel therapies and technologies to ultimately cure disease. The researchers’ relentless drive in support of this mission relies on understanding the real-world circumstances of people living with chronic diseases, and focusing on the interface between biology, behavior and technology.
Specifically, Dr. Wesley and her team research curative and preventative therapies for chronic metabolic diseases, including diabetic kidney disease and type 1 diabetes. This work involves characterization of the disease pathology in humans, translational biomarkers for predicting drug responses and disease outcome, and novel in vitro platform development for screening compounds and mechanistic studies.
Dr. Grove is passionate about understanding the biology of obesity and associated metabolic complications to find potential new treatments for people. With his team, Dr. Grove researches the biologic underpinnings of obesity and liver disease with a biological focus in brain, muscle, liver and adipose tissues.
